SHELLEY SASSAMAN: Open Payments
NPI 1609875632 · HOMETOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,931 in 134 payments from 14 companies in 2025. Trend: 2023 $13,635 · 2024 $26,081 · 2025 $12,931
Speaker / faculty: $11,400Food & beverage: $1,462Education: $69
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 46 | $11,445 |
| Xeris Pharmaceuticals, Inc. | 17 | $300 |
| Corcept Therapeutics | 17 | $266 |
| Amgen Inc. | 16 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $198 |
| Novo Nordisk Inc | 12 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Lilly USA, LLC | 3 | $60 |
| Sequel Med Tech, LLC | 2 | $42 |
Products named: MINIMED 780G, Korlym, Kerendia, RECORLEV, JARDIANCE, GVOKE HYPOPEN, REPATHA, Ozempic.
Industry payments across PA — which companies pay providers there.
